Medicare Enrolled

Dr. Ting Wu

Neurology · Concord, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
133 OLD ROAD TO 9 ACRE COR, Concord, MA 01742
7745734434
In practice since 2014 (12 years)
NPI: 1730594243 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wu

Dr. Ting Wu is a neurology specialist in Concord, MA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Wu performed 343 Medicare services across 314 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wu received a total of $4,930 from 38 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 49% volume in MA $4,930 industry payments

Medicare Practice Summary

Medicare Utilization ↗
343
Medicare services
Top 49% in MA for neurology
314
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $78 $372
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $100 $437
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
49 $119 $564
New patient office visit, complex (60-74 min) 45 $186 $742
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
42 $96 $539
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
34 $148 $608
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
22 $147 $652
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,930
Total received (2021-2024)
Avg $1,643/year across 3 years
Top 35% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
201
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,930 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,288
2023
$601
2021
$41

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$898
PFIZER INC.
$448
UCB, Inc.
$332
Biogen, Inc.
$284
Eisai Inc.
$233
Lilly USA, LLC
$179
Otsuka America Pharmaceutical, Inc.
$170
ACADIA Pharmaceuticals Inc
$165
Celgene Corporation
$140
SK Life Science, Inc.
$112
Alexion Pharmaceuticals, Inc.
$96
TG Therapeutics, Inc.
$94
Lundbeck LLC
$87
Amneal Pharmaceuticals LLC
$79
Neurocrine Biosciences, Inc.
$78
Genentech USA, Inc.
$77
EMD Serono, Inc.
$77
Kyowa Kirin, Inc.
$76
Boston Scientific Corporation
$73
Vanda Pharmaceuticals Inc.
$56
Teva Pharmaceuticals USA, Inc.
$55
ARGENX US, INC.
$53
Alnylam Pharmaceuticals Inc.
$53
MDD US Operations, LLC
$45
InSightec,Inc
$38
Novartis Pharmaceuticals Corporation
$34
Ipsen Biopharmaceuticals, Inc
$33
Life Molecular Imaging Ltd
$32
LivaNova USA, Inc.
$28
AstraZeneca Pharmaceuticals LP
$27
CATALYST PHARMACEUTICALS, INC.
$26
GENZYME CORPORATION
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Amylyx Pharmaceuticals, Inc.
$22
Sumitomo Pharma America, Inc.
$20
NEUROPACE, INC.
$16
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$898
PFIZER INC.
$546
UCB, Inc.
$454
Biogen, Inc.
$327
Eisai Inc.
$255
Lilly USA, LLC
$202
Otsuka America Pharmaceutical, Inc.
$193
Celgene Corporation
$174
ACADIA Pharmaceuticals Inc
$165
SK Life Science, Inc.
$136
Kyowa Kirin, Inc.
$125
Alexion Pharmaceuticals, Inc.
$123
Genentech USA, Inc.
$105
Teva Pharmaceuticals USA, Inc.
$102
TG Therapeutics, Inc.
$94
Lundbeck LLC
$87
Amneal Pharmaceuticals LLC
$79
Neurocrine Biosciences, Inc.
$78
EMD Serono, Inc.
$77
Boston Scientific Corporation
$73
MDD US Operations, LLC
$63
Vanda Pharmaceuticals Inc.
$56
Novartis Pharmaceuticals Corporation
$56
ARGENX US, INC.
$53
Alnylam Pharmaceuticals Inc.
$53
InSightec,Inc
$38
Takeda Pharmaceuticals U.S.A., Inc.
$35
Ipsen Biopharmaceuticals, Inc
$33
Life Molecular Imaging Ltd
$32
AbbVie Inc.
$29
LivaNova USA, Inc.
$28
AstraZeneca Pharmaceuticals LP
$27
CATALYST PHARMACEUTICALS, INC.
$26
GENZYME CORPORATION
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Amylyx Pharmaceuticals, Inc.
$22
Sumitomo Pharma America, Inc.
$20
NEUROPACE, INC.
$16
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
AMYVID · APTIOM · AUSTEDO · AVONEX · Apokyn · Austedo XR · BOTOX · BRIUMVI · Briviact · Dysport · EMGALITY · Exablate · FIRDAPSE · GOCOVRI · Gocovri · INGREZZA · KESIMPTA · KISUNLA · Leqembi · NEURACEQ · NUPLAZID · NURTEC ODT · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ocrevus · PONVORY · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Rystiggo · SKYCLARYS · TYSABRI · UBRELVY · ULTOMIRIS · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XCOPRI · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Concord?
Compare neurologists in the Concord area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
679
Per 100K population
41.8
County median income
$126,779
Nearest hospital
EMERSON HOSPITAL -
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wu experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Wu performed 78 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wu receive payments from pharmaceutical companies?
Yes. Dr. Wu received a total of $4,930 from 38 companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wu's costs compare to other neurologists in Concord?
Dr. Wu's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →